Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Sequential Azacitidine vs Azacitidine in MDS-RS
NCT06004765Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lenalidomide in myelodysplastic syndromes with ring sideroblasts (MDS-RS), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
myelodysplastic syndromes with ring sideroblasts (MDS-RS)
Beyond the preview
Go deeper on NCT06004765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06004765.